Publications by authors named "I Zuazu"
Article Synopsis
- Atresia of the inferior vena cava (IVC) is a rare congenital condition linked to a high risk of blood clots, possibly due to thrombosis occurring during fetal development.
- A study evaluated the connection between IVC atresia and severe thrombophilia, particularly in patients with the homozygous SERPINC1 variant, identifying IVC abnormalities in 70.8% of those analyzed.
- The findings suggest that a thrombosis in fetal vessels might cause IVC atresia, prompting further research into the relationship between severe thrombophilia and this vascular defect.
Background And Purpose: Ultrasound (US) is one of the most common modalities used in intervention for musculoskeletal disorders, although its effectiveness is debated. The purpose of this case report is to describe the intervention, including the use of US, in the management of a large rectus sheath hematoma (RSH) in a patient receiving anticoagulant therapy.
Case Description: The patient was a 62-year-old woman with RSH who was receiving oral anticoagulant therapy and had a history of bouts of coughing.
Background: Recent studies have shown that hepatitis C virus (HCV) can be detected in peripheral blood mononuclear cells of patients who are negative for the presence of anti-HCV and serum HCV RNA. The aim of the study was to evaluate the prevalence of HCV viremia in granulocyte colony-stimulating factor (G-CSF) mobilized peripheral blood progenitor cell (PBPC) donors by the use of a free HCV core antigen enzyme-linked immunosorbent assay (ELISA).
Study Design And Methods: A total of 28 samples from consecutive PBPC donors that were mobilized with G-CSF, and 13 samples from patients presenting with leukocytosis of greater than 20 x 10(9) per L from other causes, were tested by a free HCV core antigen ELISA.
Background: The purpose of this study was to describe our experience in the conservative management of large rectus sheath hematoma (RSH) in patients undergoing anticoagulation therapy.
Methods: This is a retrospective study of the medical histories of 12 cases of RSH (11 female, one male; mean age = 67.6 years).
We have developed a simple assay that measures the circulating activated protein C (APC) in plasma. The assay requires collection of duplicate blood samples, one in citrate plus heparin and the other in citrate plus inhibitors of the enzyme. In the heparin tube, APC reacts completely and irreversibly with its major plasma inhibitors, protein C inhibitor (PCI) and alpha 1-antitrypsin (alpha 1AT), and the complexes formed are measured by ELISAs.
View Article and Find Full Text PDF